DOP2005000210A - ANTIBONY FORMULATIONS - Google Patents

ANTIBONY FORMULATIONS

Info

Publication number
DOP2005000210A
DOP2005000210A DO2005000210A DO2005000210A DOP2005000210A DO P2005000210 A DOP2005000210 A DO P2005000210A DO 2005000210 A DO2005000210 A DO 2005000210A DO 2005000210 A DO2005000210 A DO 2005000210A DO P2005000210 A DOP2005000210 A DO P2005000210A
Authority
DO
Dominican Republic
Prior art keywords
formulations
antibony
antibody
binds
formulation
Prior art date
Application number
DO2005000210A
Other languages
Spanish (es)
Inventor
Shiang C Gwee
Jun Liu
Ye Shen
D Andya James D James
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority to DO2005000210A priority Critical patent/DOP2005000210A/en
Publication of DOP2005000210A publication Critical patent/DOP2005000210A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present application describes antibody formulations, including monoclonal antibodies formulated in histidine-acetate buffer, as well as a formulation comprising an antibody that binds to domain 11 of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 (for example, Apomab).The present application describes antibody formulations, including monoclonal antibodies formulated in histidine-acetate buffer, as well as a formulation comprising an antibody that binds to domain 11 of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 ( for example, Apomab).

DO2005000210A 2005-10-19 2005-10-19 ANTIBONY FORMULATIONS DOP2005000210A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2005000210A DOP2005000210A (en) 2005-10-19 2005-10-19 ANTIBONY FORMULATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2005000210A DOP2005000210A (en) 2005-10-19 2005-10-19 ANTIBONY FORMULATIONS

Publications (1)

Publication Number Publication Date
DOP2005000210A true DOP2005000210A (en) 2006-04-30

Family

ID=44340200

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2005000210A DOP2005000210A (en) 2005-10-19 2005-10-19 ANTIBONY FORMULATIONS

Country Status (1)

Country Link
DO (1) DOP2005000210A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11634485B2 (en) 2019-02-18 2023-04-25 Eli Lilly And Company Therapeutic antibody formulation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11634485B2 (en) 2019-02-18 2023-04-25 Eli Lilly And Company Therapeutic antibody formulation

Similar Documents

Publication Publication Date Title
TW200618811A (en) Antibody formulations
NO20083895L (en) Anti-IGF-1R human monoclonal antibody formulation
MY169272A (en) Her2 antibody composition
NO20081124L (en) Anti-CD 3 antibody formulations
ATE537189T1 (en) ANTI-TFR ANTIBODIES
TNSN08511A1 (en) Lyophilized formulations of anti-egfr antibodies
EA200802168A1 (en) HUMANIZED ANTIBODY TO C-KIT
MY163480A (en) Sclerostin binding agents
UA101487C2 (en) Humanized b-ly1 antibody formulation
MX2009006594A (en) Formulations.
CR9186A (en) COMPOSITIONS AND PROCEDURES CONCERNING ANTIBODIES AGAINST THE IGF-1 RECEIVER
UA106194C2 (en) Diagnosis and treatment of cancer using anti-ereg antibody
PE20090738A1 (en) ANTIBODY FORMULATIONS
WO2007016285A3 (en) M-csf specific monoclonal antibody and uses thereof
UA109633C2 (en) HUMAN ANTIBODY AGAINST TISSUE FACTOR
MX348432B (en) Sclerostin epitopes.
CR11399A (en) ANTI-BODIES ANTI-IL-12 / 23p40, EPITHOPES, FORMULATIONS, COMPOSITIONS, METHODS AND USES
EP4406607A3 (en) Antibodies for chelated radionuclides
UA109148C2 (en) Compositions based on anti-vegfr-3 antibody
DOP2005000210A (en) ANTIBONY FORMULATIONS
UA98100C2 (en) Humanized monoclonal antibody that binds and neutralizes human nogo
CY1113407T1 (en) ANTIBODY PREPARATION IN STRUCTURAL-ACETIC SOLUTION SOLUTION
TH84864B (en) Antibody formula
TH84864A (en) Antibody formula
EA202190387A1 (en) ANTIBODY TO HUMAN CD38 AND ITS USE